


Ask a doctor about a prescription for ARTILOG 200 mg HARD CAPSULES
Package Leaflet: Information for the User
Artilog 200 mg Hard Capsules
celecoxib
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Artilog belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), and more specifically to the subgroup known as selective cyclooxygenase-2 (COX-2) inhibitors. Your body produces prostaglandins that can cause pain and inflammation. In conditions such as rheumatoid arthritis or osteoarthritis, your body produces them in larger quantities. Artilog works by reducing the production of prostaglandins, thus reducing pain and inflammation.
Artilog is indicated in adults to relieve the signs and symptoms of rheumatoid arthritis, osteoarthritis, andankylosing spondylitis.
The medicine will start to take effect a few hours after taking the first dose, but you may not experience a full effect until several days have passed.
Your doctor has prescribed Artilog for you. The following information will help you get better results with Artilog. If you have any other questions, please ask your doctor or pharmacist.
Do not take Artilog
Tell your doctor if any of the following circumstances apply to you, as patients with these conditions should not take Artilog:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Artilog:
As with other anti-inflammatory medicines (e.g. ibuprofen or diclofenac), this medicine may increase your blood pressure, so your doctor may perform periodic blood pressure checks.
Some cases of severe liver reactions have been reported with celecoxib, including severe liver inflammation, liver damage, liver failure (some with a fatal outcome or requiring liver transplantation). Of the cases in which it was reported when the event started, most severe liver reactions occurred within the first month of treatment.
Artilog may make it difficult to become pregnant. You should inform your doctor if you intend to become pregnant or if you are having difficulty becoming pregnant (see section Pregnancy and breastfeeding).
Using Artilog with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines:
Artilog can be taken with low doses of acetylsalicylic acid (75 mg daily or less). Ask your doctor for advice before taking both medicines together.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Artilog should not be used by pregnant women or women who may become pregnant (i.e. women of childbearing potential who do not use a suitable contraceptive method) during treatment. If you become pregnant during treatment with Artilog, you should stop treatment and contact your doctor for alternative treatment.
Breastfeeding
Artilog should not be used during breastfeeding.
Fertility
NSAIDs, including Artilog, may make it difficult to become pregnant. You should inform your doctor if you plan to become pregnant or if you are having difficulty becoming pregnant.
Driving and using machines
You should know how you react to Artilog before driving or using machinery. If you feel dizzy or drowsy after taking Artilog, do not drive or operate machinery until these effects have passed.
Artilog contains lactose
This medicine contains
Artilog contains sodium
This medicine contains less than 23 mg of
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again. If you think the effect of Artilog is too strong or too weak, tell your doctor or pharmacist.
Your doctor will tell you what dose to take. Since the risk of side effects associated with heart problems may increase with the dose and duration of treatment, it is important that you use the lowest dose that controls your pain and do not take Artilog for longer than necessary to control the symptoms.
Method of administration
Artilog should be taken orally.The capsules can be taken at any time of day, with or without food. However, try to take each dose of Artilog at the same time each day.
If you have difficulty swallowing the capsules: you can sprinkle the entire contents of the capsule onto a level teaspoon of some semi-solid food (such as apple sauce, rice, yogurt, or mashed banana at room temperature or cold) and swallow it immediately with a glass of water of approximately 240 ml.
To open the capsule, hold it in a vertical position to keep the granules at the bottom; then squeeze the top and twist it to remove it, being careful not to spill the contents. Do not chew or crush the granules.
Contact your doctor if, after two weeks of treatment, you do not experience an improvement.
The recommended dose is:
The dose is usually:
The recommended dose for the treatment of ankylosing spondylitisis 200 mg per day, if necessary, your doctor may increase it up to a maximum of 400 mg.
The dose is usually:
Kidney or liver problems:make sure your doctor knows if you have liver or kidney problems, as you may need a lower dose.
Patients over 65 years old, especially those weighing less than 50kg:your doctor may want to monitor you more closely if you are over 65 years old and especially if you weigh less than 50 kg.
Do not take more than 400 mg per day.
Use in children
Artilog is for adults only, it is not indicated in children.
If you take more Artilog than you should
Do not take more capsules than your doctor has told you. If you take more Artilog than you should, contact your doctor, pharmacist, or hospital immediately and take the medicine with you.
If you forget to take Artilog
If you forget to take a capsule, take it as soon as you remember. Do not take a double dose to make up for forgotten doses.
If you stop taking Artilog
Stopping treatment with Artilog abruptly may cause a worsening of symptoms. Do not stop taking Artilog unless your doctor tells you to. Your doctor will tell you to reduce the dose over a few days before stopping treatment completely.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The adverse effects mentioned below were observed in patients with arthritis who took Artilog. The adverse effects marked with an asterisk (*) occurred in patients who took Artilog for the prevention of colon polyps and have been classified taking into account the highest frequency of occurrence. The patients included in these studies took Artilog at high doses and for a prolonged period of time.
If you experience any of the following adverse effects, discontinue treatment with Artilog and inform your doctor immediately:
If you have:
Very frequent adverse effects: may affect more than 1 in 10 patients:
Frequent adverse effects: may affect up to 1 in 10 patients:
Uncommon adverse effects: may affect up to 1 in 100 patients:
Rare adverse effects: may affect up to 1 in 1,000 patients:
Very rare adverse effects: may affect up to 1 in 10,000 patients:
Adverse effects of unknown frequency: their frequency cannot be estimated from the available data:
Adverse effects reported in clinical trials in which Artilog was administered at doses of 400 mg per day for a period of up to 3 years, in patients with diseases unrelated to arthritis or other arthritic conditions, were:
Frequent adverse effects: may affect up to 1 in 10 patients:
Uncommon adverse effects: may affect up to 1 in 100 patients:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Artilog
The active ingredient is celecoxib.
Each capsule contains 200 mg of celecoxib.
The other ingredients (excipients) are:
Lactose monohydrate, sodium lauryl sulfate, povidone, sodium croscarmellose, magnesium stearate. The capsule shell contains gelatin, titanium dioxide (E-171), sodium lauryl sulfate and sorbitan monolaurate. The printing ink contains shellac lacquer, propylene glycol and iron oxide (E-172).
Appearance of the product and package contents
Artilog is presented in the form of capsules.
The capsules are opaque, white in color, with two golden bands and bear the marks "7767" and "200".
The capsules are presented in transparent or opaque PVC/aluminum blisters.
Artilog may be presented in packages of 2, 5, 6, 10, 20, 30, 40, 50, 60, 100, 10x10, 10x30, 10x50, 1x50 unit dose, 1x100 unit dose, and 5x(10x10).
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Klocke Verpackungs-Service GmbH
Max-Becker-Str. 6
76356 Weingarten (Baden)
Germany
or
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
or
Mylan Hungary Kft.
Mylan utca 1
Komárom, 2900
Hungary
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
Calle General Aranaz, 86
28027 Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Name | Country |
Aclarex | Greece |
Artilog | Spain |
Solexa | Portugal, Sweden |
Date of last revision of this prospectus: April 2021
Other sources of information
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ARTILOG 200 mg HARD CAPSULES in November, 2025 is around 22.28 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ARTILOG 200 mg HARD CAPSULES – subject to medical assessment and local rules.